On Wednesday, Vincerx Pharma Inc (VINC) stock saw a decline, ending the day at $1.56 which represents a decrease of $-0.09 or -5.45% from the prior close of $1.65. The stock opened at $1.97 and ...

In terms of valuation, Vincerx Pharma Inc’s market capitalization stands at $3.62 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...

In a turbulent market environment, VINC stock has reached its 52-week low, trading at $1.62, with technical indicators from InvestingPro showing the stock in oversold territory. This price level ...

Companies also provide insights into proposed strategic mergerSAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx ...

Daniel Hemetsberger narrowly missed out on the downhill podium in fourth place at the Hahnenkamm race in Kitzbühel. However, ...

EST Vincerx Pharma (VINC) files $100M mixed securities shelfInvest with Confidence: Follow TipRanks' Top Wall Street Analysts to uncover ...

The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.

The proud Western New York municipality of Buffalo is in the midst of a unique interval of sporting success, built largely ...

After their somewhat lopsided loss to Toronto, Calgary slides two spots in the Power Rankings this week. How much can we ...

SAN MATEO, Calif. - Vincerx Pharma, Inc. (NASDAQ:VINC), a clinical-stage biopharmaceutical company with a current market capitalization of $2.77 million, and Oqory, Inc. announced promising results ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...